Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
9 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
138.3 rhumatos / 100 000 hab. — département bien doté
10 publications sur 5 ans↗
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
6
6 articles ont été cités au moins 6fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
90
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
19
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
3
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Prognostic factors after therapeutic bronchoscopy for tracheo- or broncho-oesophageal fistulas: results from the EpiGETIF registry
2025ArticleERJ Open Research
Therapeutic bronchoscopy for malignant central airway obstruction: Introduction to the EpiGETIF registry
2024ArticleRespirology
Experience with Transcordal Silicone Stents in Adult Laryngotracheal Stenosis: A Bicentric Retrospective Study
2018ArticleRespiration
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CH PERPIGNAN
20 AV DU LANGUEDOC BP 49954, 66046 PERPIGNAN CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Respiration; international review of thoracic diseases · 2018
<b><i>Background:</i></b> Benign stenosis involving laryngeal and upper tracheal structures represents a therapeutic challenge. Open surgery and endoscopic management have to be discussed by a multidisciplinary board in order to evaluate the risk and benefit for each patient. <b><i>Objective:</i></b> The objective of this retrospective study was to report the experience of two French centers with transcordal silicone stents (TSS) in the endoscopic management of benign laryngotracheal stenosis (BLTS) in adults, with focus on efficacy, safety, and tolerability. <b><i>Methods:</i></b> We performed a retrospective chart review of all cases of BLTS treated with TSS between January 2001 and June 2017 at two tertiary centers in France: the Centre Hospitalier Régional Universitaire de Strasbourg and the Hôpital Nord de Marseille. <b><i>Results:</i></b> A total of 17 patients were included. Eleven had a tracheostomy at initial management which consisted of 8 T-tubes and 9 strictly endoluminal stents placements. The main complications were minor aspirations in 5 patients (29%), granulation in 3 patients (18%), migration in 2 patients (12%), and severe dysphonia in 3 patients (18%). After a mean duration of 18.3 months, 11 patients (65%) had had their TSS definitely removed, 13 patients were tracheostomy free (76%), and a TSS remained in place in 4 patients (24%). <b><i>Conclusions:</i></b> Adult BLTS treatment with TSS placement is associated with low morbidity and excellent clinical outcomes, with a large proportion of patients free of airway instrumentation on long-term follow-up.
Respirology (Carlton, Vic.) · 2024
AbstractBackground and ObjectiveEpiGETIF is a web‐based, multicentre clinical database created in 2019 aiming for prospective collection of data regarding therapeutic rigid bronchoscopy (TB) for malignant central airway obstruction (MCAO).MethodsPatients were enrolled into the registry from January 2019 to November 2022. Data were prospectively entered through a web‐interface, using standardized definitions for each item. The objective of this first extraction of data was to describe the population and the techniques used among the included centres to target, facilitate and encourage further studies in TB.ResultsOverall, 2118 patients from 36 centres were included. Patients were on average 63.7 years old, mostly male and smokers. Most patients had a WHO score ≤2 (70.2%) and 39.6% required preoperative oxygen support, including mechanical ventilation in 6.7%. 62.4% had an already known histologic diagnosis but only 46.3% had received any oncologic treatment. Most tumours were bronchogenic (60.6%), causing mainly intrinsic or mixed obstruction (43.3% and 41.5%, respectively). Mechanical debulking was the most frequent technique (67.3%), while laser (9.8%) and cryo‐recanalization (2.7%) use depended on local expertise. Stenting was required in 54.7%, silicone being the main type of stent used (55.3%). 96.3% of procedure results were considered at least partially successful, resulting in a mean 4.1 points decrease on the Borg scale of dyspnoea. Complications were noted in 10.9%.ConclusionThis study exposes a high volume of TB that could represent a good source of future studies given the dismal amount of data about the effects of TB in certain populations and situations.
The clinical respiratory journal · 2018
AbstractObjectiveMetastatic pleural effusion (MPE) is one of the most frequent causes of pleural effusion. The aims of the therapeutic management are palliation of symptoms and improvement in patient’s quality of life. The first step is a therapeutic thoracentesis. In case of a recurrent MPE, pleural maneuvers can be used to manage symptoms based on either ambulatory pleural drainage or pleurodesis to prevent fluid accumulation. The aim of this review is to describe recent advances, according to the best available evidence, in the field of pleurodesis for the management of MPE.Data source and study selectionThree different searches of the most clinically relevant articles and up‐to‐date results in the field of pleurodesis for the management of MPE were performed using PubMed. Different indexing terms and time restriction were chosen. From these PubMed searches, 322 articles were respectively found. After cross‐checking these three lists and the selection of articles published after January 2010 specially dedicated to the management of MPE by pleurodesis, the abstracts of 106 articles were extracted to feed the corpus of this review.Results and conclusionTreatment approaches of recurrent MPE should take into account multiple factors in particular patient’s life expectancy and preference. If talc is the best sclerosing agent alone or in combination with indwelling pleural catheter which is a promising strategy, the pathophysiology of MPE has to be revisited in order to propose a personalized management targeting intrapleural key molecules involved in the genesis of malignant process.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Archivos de bronconeumologia · 2025 · Case Reports
Tronchetti J, Roy P, Laroumagne S, Lovato JB, et al.
ERJ open research · 2025 · Journal Article
Edme J, Fournier C, Lepage B, Zea Obando Ep Chateau C, et al.
Respiration; international review of thoracic diseases · 2025 · Journal Article
Roy P, Roy P, Amari L, Laroumagne S, et al.
Respirology (Carlton, Vic.) · 2024 · Journal Article
Daigmorte C, Usturoi D, Fournier C, Wallyn F, et al.
Respirology (Carlton, Vic.) · 2024 · Journal Article
Guibert N, Roy P, Amari L, Legodec J, et al.
Respiration; international review of thoracic diseases · 2025 · Journal Article
Roy P, Roy P, Amari L, Laroumagne S, et al.
Respiration; international review of thoracic diseases · 2018 · Case Reports
Guinde J, Georges S, Bourinet V, Laroumagne S, et al.
Respiration; international review of thoracic diseases · 2018 · Journal Article
Bourinet V, Raguin T, Fortin M, Chetrit E, et al.
Journal of thoracic disease · 2019 · Journal Article
Thiam K, Guinde J, Laroumagne S, Bourinet V, et al.
The clinical respiratory journal · 2018 · Comparative Study
Guinde J, Georges S, Bourinet V, Laroumagne S, et al.